vs
Side-by-side financial comparison of EURONET WORLDWIDE, INC. (EEFT) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.1B, roughly 1.4× EURONET WORLDWIDE, INC.). EURONET WORLDWIDE, INC. runs the higher net margin — 4.7% vs 4.4%, a 0.2% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 5.9%). EURONET WORLDWIDE, INC. produced more free cash flow last quarter ($434.3M vs $379.8M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 13.7%).
Euronet Worldwide is an American provider of global electronic payment services with headquarters in Leawood, Kansas. It offers automated teller machines (ATM), point of sale (POS) services, credit/debit card services, currency exchange and other electronic financial services and payments software. Among others, it provides the prepaid subsidiaries Transact, PaySpot, epay, Movilcarga, TeleRecarga and ATX.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
EEFT vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.5B |
| Net Profit | $51.8M | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | 9.1% | 12.4% |
| Net Margin | 4.7% | 4.4% |
| Revenue YoY | 5.9% | 32.8% |
| Net Profit YoY | 14.3% | 143.8% |
| EPS (diluted) | $0.97 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $915.5M | $1.1B | ||
| Q4 24 | $1.0B | $1.1B | ||
| Q3 24 | $1.1B | $1.0B | ||
| Q2 24 | $986.2M | $929.2M | ||
| Q1 24 | $857.0M | $751.7M |
| Q4 25 | $51.8M | $66.5M | ||
| Q3 25 | $122.0M | $124.8M | ||
| Q2 25 | $97.6M | $94.3M | ||
| Q1 25 | $38.4M | $1.3M | ||
| Q4 24 | $45.3M | $-151.9M | ||
| Q3 24 | $151.5M | $-121.3M | ||
| Q2 24 | $83.1M | $-120.4M | ||
| Q1 24 | $26.2M | $-251.2M |
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% | ||
| Q1 24 | — | 83.4% |
| Q4 25 | 9.1% | 12.4% | ||
| Q3 25 | 17.0% | 11.5% | ||
| Q2 25 | 14.8% | 6.7% | ||
| Q1 25 | 8.2% | 1.0% | ||
| Q4 24 | 11.7% | -7.0% | ||
| Q3 24 | 16.6% | -12.0% | ||
| Q2 24 | 13.6% | -11.5% | ||
| Q1 24 | 7.5% | -34.8% |
| Q4 25 | 4.7% | 4.4% | ||
| Q3 25 | 10.6% | 8.8% | ||
| Q2 25 | 9.1% | 7.2% | ||
| Q1 25 | 4.2% | 0.1% | ||
| Q4 24 | 4.3% | -13.5% | ||
| Q3 24 | 13.8% | -12.1% | ||
| Q2 24 | 8.4% | -13.0% | ||
| Q1 24 | 3.1% | -33.4% |
| Q4 25 | $0.97 | $0.05 | ||
| Q3 25 | $2.75 | $0.08 | ||
| Q2 25 | $2.27 | $0.06 | ||
| Q1 25 | $0.85 | $0.00 | ||
| Q4 24 | $0.96 | $-0.10 | ||
| Q3 24 | $3.21 | $-0.09 | ||
| Q2 24 | $1.73 | $-0.09 | ||
| Q1 24 | $0.55 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.0B | $4.5B |
| Total DebtLower is stronger | $1.0B | $836.4M |
| Stockholders' EquityBook value | $1.3B | $4.4B |
| Total Assets | $6.5B | $8.2B |
| Debt / EquityLower = less leverage | 0.79× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.0B | $4.5B | ||
| Q3 25 | $1.2B | $4.0B | ||
| Q2 25 | $1.3B | $2.8B | ||
| Q1 25 | $1.4B | $2.5B | ||
| Q4 24 | $1.3B | $2.6B | ||
| Q3 24 | $1.5B | $2.7B | ||
| Q2 24 | $1.3B | $2.6B | ||
| Q1 24 | $1.2B | $2.8B |
| Q4 25 | $1.0B | $836.4M | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $1.3B | — |
| Q4 25 | $1.3B | $4.4B | ||
| Q3 25 | $1.3B | $4.1B | ||
| Q2 25 | $1.4B | $3.8B | ||
| Q1 25 | $1.3B | $3.5B | ||
| Q4 24 | $1.2B | $3.3B | ||
| Q3 24 | $1.4B | $3.4B | ||
| Q2 24 | $1.2B | $3.4B | ||
| Q1 24 | $1.2B | $3.4B |
| Q4 25 | $6.5B | $8.2B | ||
| Q3 25 | $6.3B | $7.6B | ||
| Q2 25 | $6.6B | $6.3B | ||
| Q1 25 | $6.1B | $5.8B | ||
| Q4 24 | $5.8B | $5.9B | ||
| Q3 24 | $6.3B | $5.8B | ||
| Q2 24 | $6.1B | $5.7B | ||
| Q1 24 | $5.7B | $5.7B |
| Q4 25 | 0.79× | 0.19× | ||
| Q3 25 | 0.85× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 1.46× | — | ||
| Q4 24 | 0.92× | — | ||
| Q3 24 | 0.88× | — | ||
| Q2 24 | 0.85× | — | ||
| Q1 24 | 1.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $559.8M | $417.3M |
| Free Cash FlowOCF − Capex | $434.3M | $379.8M |
| FCF MarginFCF / Revenue | 39.2% | 25.4% |
| Capex IntensityCapex / Revenue | 11.3% | 2.5% |
| Cash ConversionOCF / Net Profit | 10.81× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $722.3M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $559.8M | $417.3M | ||
| Q3 25 | $197.3M | $402.6M | ||
| Q2 25 | $182.9M | $263.6M | ||
| Q1 25 | $1.7M | $44.1M | ||
| Q4 24 | $732.8M | $75.2M | ||
| Q3 24 | $440.3M | $188.4M | ||
| Q2 24 | $182.2M | $-95.6M | ||
| Q1 24 | $30.0M | $-308.6M |
| Q4 25 | $434.3M | $379.8M | ||
| Q3 25 | $161.2M | $354.5M | ||
| Q2 25 | $148.3M | $219.8M | ||
| Q1 25 | $-21.5M | $-12.3M | ||
| Q4 24 | $615.6M | $-17.3M | ||
| Q3 24 | $414.5M | $54.7M | ||
| Q2 24 | $148.8M | $-205.5M | ||
| Q1 24 | $6.2M | $-465.1M |
| Q4 25 | 39.2% | 25.4% | ||
| Q3 25 | 14.1% | 25.1% | ||
| Q2 25 | 13.8% | 16.7% | ||
| Q1 25 | -2.3% | -1.1% | ||
| Q4 24 | 58.8% | -1.5% | ||
| Q3 24 | 37.7% | 5.5% | ||
| Q2 24 | 15.1% | -22.1% | ||
| Q1 24 | 0.7% | -61.9% |
| Q4 25 | 11.3% | 2.5% | ||
| Q3 25 | 3.2% | 3.4% | ||
| Q2 25 | 3.2% | 3.3% | ||
| Q1 25 | 2.5% | 5.0% | ||
| Q4 24 | 11.2% | 8.2% | ||
| Q3 24 | 2.3% | 13.3% | ||
| Q2 24 | 3.4% | 11.8% | ||
| Q1 24 | 2.8% | 20.8% |
| Q4 25 | 10.81× | 6.28× | ||
| Q3 25 | 1.62× | 3.22× | ||
| Q2 25 | 1.87× | 2.79× | ||
| Q1 25 | 0.04× | 34.71× | ||
| Q4 24 | 16.18× | — | ||
| Q3 24 | 2.91× | — | ||
| Q2 24 | 2.19× | — | ||
| Q1 24 | 1.15× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
